Medical Condition

irritable bowel syndrome

Total Trials

12

Recruiting Now

12

Trial Phases

Phase 4, Phase 2, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for irritable bowel syndrome sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
Phase 1–4 studies from early safety trials to post-marketing surveillance
NIH, pharmaceutical sponsor, and academic medical center studies worldwide
AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — irritable bowel syndrome Clinical Trials

How many clinical trials are currently recruiting for irritable bowel syndrome?

ClinicalMetric currently tracks 12 actively recruiting clinical trials for irritable bowel syndrome, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for irritable bowel syndrome?

irritable bowel syndrome research spans Phase 1 (1 trial), Phase 2 (5 trials), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a irritable bowel syndrome clinical trial?

Eligibility criteria for irritable bowel syndrome trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 3

Phase 4

Universitair Ziekenhuis Brusse...

View Trial →

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology

irritable bowel syndrome

Frequently Asked Questions — irritable bowel syndrome Clinical Trials

Recruiting Clinical Trials

Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome

A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)

Mechanisms of Gulf War Illness

Fecal Microbiota Transplantation for Irritable Bowel Syndrome

Fecal Amino Acids，Gut Taste Receptors and Irritable Bowel Syndromes

Drug Interaction Potential of Pro-Inflammatory Conditions

Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

Effectiveness of a Dietary Supplement in Irritable Bowel Syndrome

Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers.

Efficacy of the DOMINO Diet App in IBS

Fecal Microbiota Transplantation for IBS

Reliability of a Food Frequency Questionnaire in the Assessment of Dietary Intake Including FODMAPs in Different Populations, and Relationship With IBS Symptoms and the Degree of Self-assessed Physical Activity